Related Experiment Video
Updated: Mar 23, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor
Francheska Delgado-Peraza1, Kwang H Ahn1, Carlos Nogueras-Ortiz1
1Department of Anatomy and Neurobiology (F.D.-P., G.A.Y.) and Institute of Neurobiology (F.D.-P., C.N.-O., G.A.Y.), University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (K.H.A., D.A.K.); Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (I.N.M.); and Department of Psychological & Brain Sciences, Gill Center for Biomedical Sciences, Indiana University, Bloomington, Indiana (K.M.).
Abstract:
Activation of G protein-coupled receptors results in multiple waves of signaling that are mediated by heterotrimeric G proteins and the scaffolding proteins β-arrestin 1/2. Ligands can elicit full or subsets of cellular responses, a concept defined as ligand bias or functional selectivity. However, our current understanding of β-arrestin-mediated signaling is still very limited. Here we provide a comprehensive view of β-arrestin-mediated signaling from the cannabinoid 1 receptor (CB1R). By using a signaling biased receptor, we define the cascades, specific receptor kinases, and molecular mechanism underlying β-arrestin-mediated signaling: We identify the interaction kinetics of CB1R and β-arrestin 1 during their endocytic trafficking as directly proportional to its efficacy. Finally, we demonstrate that signaling results in the control of genes clustered around prosurvival and proapoptotic functions among others. Together, these studies constitute a comprehensive description of β-arrestin-mediated signaling from CB1Rs and suggest modulation of receptor endocytic trafficking as a therapeutic approach to control β-arrestin-mediated signaling.
Insights
This study details β-arrestin signaling from the cannabinoid 1 receptor (CB1R), revealing its molecular mechanisms and therapeutic potential. Modulating receptor endocytic trafficking offers a new approach to control β-arrestin-mediated cellular responses.
Area of Science:
- Molecular Pharmacology
- Cellular Signaling
- G protein-coupled receptor (GPCR) research
Background:
- G protein-coupled receptors (GPCRs) activate complex signaling pathways involving G proteins and β-arrestins.
- Ligand bias, or functional selectivity, allows ligands to trigger specific cellular responses.
- Understanding β-arrestin-mediated signaling remains a critical, yet limited, area of research.
Purpose of the Study:
- To comprehensively elucidate β-arrestin-mediated signaling pathways originating from the cannabinoid 1 receptor (CB1R).
- To define the molecular mechanisms, receptor kinases, and signaling cascades involved in β-arrestin recruitment and activation by CB1R.
- To explore the potential of targeting receptor endocytic trafficking for therapeutic intervention.
Main Methods:
- Utilized a signaling-biased receptor approach to dissect specific β-arrestin-mediated cascades.
- Investigated the interaction kinetics between CB1R and β-arrestin 1 during endocytic trafficking.
- Analyzed gene expression changes downstream of β-arrestin signaling, focusing on prosurvival and proapoptotic pathways.
Main Results:
- Defined the specific receptor kinases and molecular mechanisms underlying β-arrestin-mediated signaling from CB1R.
- Established a direct proportionality between CB1R-β-arrestin 1 interaction kinetics during endocytic trafficking and signaling efficacy.
- Demonstrated that CB1R signaling influences the expression of genes involved in cell survival and apoptosis.
Conclusions:
- Provided a comprehensive description of β-arrestin-mediated signaling initiated by CB1Rs.
- Identified receptor endocytic trafficking as a key determinant of β-arrestin signaling outcomes.
- Suggests that modulating receptor endocytic trafficking is a viable therapeutic strategy for controlling β-arrestin-mediated signaling.
Related Concept Videos
GPCR Desensitization
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
GPCRs Regulate Adenylyl Cylase Activity
IP3/DAG Signaling Pathway

